BRIEF-Biogen’s Imraldi granted positive opinion by committee for medicinal products for human use
June 23, 2017 at 10:05 AM EDT
* Biogen’s Imraldi, an adalimumab biosimilar candidate referencing Humira, granted positive opinion by committee for medicinal products for human use
